Emergent BioSolutions (EBS) Selling, General & Administrative (2011 - 2026)
Emergent BioSolutions (EBS) Selling, General & Administrative (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Emergent BioSolutions | 261.35 Mn | 120.45 Mn | 137.20 Mn | 44.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.60 Mn |
| Mar 31, 2026 | 46.60 Mn |
| Dec 31, 2025 | 51.10 Mn |
| Sep 30, 2025 | 38.90 Mn |
| Jun 30, 2025 | 43.70 Mn |
| Mar 31, 2025 | 52.40 Mn |
| Dec 31, 2024 | 60.80 Mn |
| Sep 30, 2024 | 76.60 Mn |
| Jun 30, 2024 | 85.90 Mn |
| Mar 31, 2024 | 84.70 Mn |
| Dec 31, 2023 | 89.70 Mn |
| Sep 30, 2023 | 86.00 Mn |
| Jun 30, 2023 | 91.40 Mn |
| Mar 31, 2023 | 101.30 Mn |
| Dec 31, 2022 | 93.40 Mn |
| Sep 30, 2022 | 81.80 Mn |
| Jun 30, 2022 | 81.10 Mn |
| Mar 31, 2022 | 84.80 Mn |
| Dec 31, 2021 | 94.50 Mn |
| Sep 30, 2021 | 82.10 Mn |